Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Flora Growth ( (FLGC) ) just unveiled an update.
On January 6, 2026, Flora Growth Corp.’s board appointed Larry Zeifman as a director and chair of the audit committee, as well as a member of the audit, compensation, and nominating and corporate governance committees, while naming Manfred Leventhal as chair of the nominating committee. Zeifman, deemed an independent director under Nasdaq and SEC standards and free of related-party or compensatory arrangements tied to his appointment, fills the board and committee vacancies created by the death of director Harold Wolkin on August 25, 2025, reinforcing Flora Growth’s governance structure and regulatory compliance credentials for investors and other stakeholders.
The most recent analyst rating on (FLGC) stock is a Hold with a $6.50 price target. To see the full list of analyst forecasts on Flora Growth stock, see the FLGC Stock Forecast page.
Spark’s Take on FLGC Stock
According to Spark, TipRanks’ AI Analyst, FLGC is a Neutral.
The score is held down primarily by weak financial performance (declining revenue, persistent losses, and ongoing cash burn) and bearish technicals (price below key moving averages with negative MACD). Corporate events provide a moderate offset via financing flexibility, but valuation is constrained by negative earnings and no dividend support.
To see Spark’s full report on FLGC stock, click here.
More about Flora Growth
Flora Growth Corp. operates in the cannabis and wellness sector, focusing on cultivating and supplying cannabis-derived products and related consumer goods for domestic and international markets.
Average Trading Volume: 36,824
Technical Sentiment Signal: Sell
Current Market Cap: $5.53M
See more data about FLGC stock on TipRanks’ Stock Analysis page.